Seattle Genetics 3Q Loss Narrows On Partnerships
BOTHELL, Wash. (AP) Development-stage biotechnology company Seattle Genetics Inc. said Thursday its third-quarter loss narrowed on higher revenue from partnerships.
The company lost $19.8 million, or 21 cents per share, compared with a loss of $21.8 million, or 27 cents per share, during the same period a year prior. Revenue rose 44 percent to $11.6 million from $8.1 million. Analysts polled by Thomson Reuters expected a loss of 25 cents per share on revenue of $9.4 million. The company's key partnership is with Genentech Inc., now part of Roche. The companies are developing potential cancer treatments. Shares of Seattle Genetics rose 12 cents to close at $9.85.- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
Connect with TheStreet
 |
 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,497.27 | 1,111.92 | 2,181.47 | 32.51 |
Oil *
79.78
|
|
UP
152.43
|
UP
16.29
|
UP
36.87
|
UP
0.50
|
10 Yr
3.25%
SPDR Gold
117.56
|
|
+1.47%
|
+1.49%
|
+1.72%
|
+1.56%
|
Data delayed 20 minutes |
